首页> 外国专利> Transdermal patch containing isosorbide dinitrate and bisoprolol

Transdermal patch containing isosorbide dinitrate and bisoprolol

机译:含有硝酸异山梨酯和比索洛尔的透皮贴剂

摘要

This invention relates to a transdermal patch in the form of a layer complex, comprising a backing layer, a drug-reservoir layer comprising pharmacologically active ingredients and pharmaceutically acceptable adjuvants, and a release liner covering the drug-reservoir layer, characterized in that the drug-reservoir layer comprises isosorbide dinitrate and Bisoprolol at a ratio of 1:3 to 3:1 by weight, as the pharmacologically active ingredients. Animal tests show that said patch can reduce the elevation of T wave of cardiogram, the increase of the level of myocardial enzyme in blood serum, and the extension of the range of myocardial infarction caused by ligating the coronary artery in animals. Results show that said patch exhibits a considerable synergistic effect in the treatment of cardiovascular diseases and has good preventive and therapeutic effects on several adverse events on heart. In addition, the animal tests show that the patch according to the invention has a better pressure-reducing effect than the application of the patch containing only one of isosorbide dinitrate and Bisoprolol, and does not worsen the arrhythmia that is easily caused by the application of the patch containing only isosorbide dinitrate or Bisoprolol.
机译:本发明涉及层复合物形式的透皮贴剂,其包括背衬层,包含药理活性成分和药学上可接受的佐剂的药物储库层,以及覆盖该药物储库层的释放衬里,其特征在于该药物-储库层包含重量比为1:3至3:1的硝酸异山梨酯和比索洛尔作为药理活性成分。动物试验表明,该贴剂可以降低动物心电图的T波升高,血清中心肌酶水平的升高以及结扎动物冠状动脉引起的心肌梗塞范围的扩大。结果表明,所述贴剂在心血管疾病的治疗中显示出显着的协同作用,并且对心脏的多种不良事件具有良好的预防和治疗作用。此外,动物试验表明,与仅包含二硝酸异山梨酯和比索洛尔中的一种的贴剂相比,根据本发明的贴剂具有更好的降压效果,并且不会恶化由应用二甲双胍引起的心律不齐。该贴剂仅包含硝酸异山梨酯或比索洛尔。

著录项

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号